Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations

This study is ongoing, but not recruiting participants.

Study NCT00010452 Information provided by FDA Office of Orphan Products Development

First Received: February 2, 2001 Last Updated: March 28, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Primary Completion Date:	June 2006 (Final data collection date for primary outcome measure)